<ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Miwa</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Kaszynski</surname><given-names>RH</given-names></name><name><surname>Hamada</surname><given-names>S</given-names></name><name><surname>Ando</surname><given-names>H</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Shirokawa</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>H</given-names></name></person-group><article-title>Abnormal pulmonary function and imaging studies in critical COVID-19 survivors at 100 days after the onset of symptoms</article-title><source>Respir Investig</source><year>2021</year><volume>59</volume><issue>5</issue><fpage>614</fpage><lpage>21</lpage><?supplied-pmid 34148855?><pub-id pub-id-type="pmid">34148855</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Miwa M, Nakajima M, Kaszynski RH, Hamada S, Ando H, Nakano T, Shirokawa M, Goto H. Abnormal pulmonary function and imaging studies in critical COVID-19 survivors at 100 days after the onset of symptoms. Respir Investig. 2021;59(5):614&#8211;21.<pub-id pub-id-type="pmid">34148855</pub-id>
</mixed-citation></citation-alternatives></ref>